IL123422A - USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS - Google Patents

USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS

Info

Publication number
IL123422A
IL123422A IL12342298A IL12342298A IL123422A IL 123422 A IL123422 A IL 123422A IL 12342298 A IL12342298 A IL 12342298A IL 12342298 A IL12342298 A IL 12342298A IL 123422 A IL123422 A IL 123422A
Authority
IL
Israel
Prior art keywords
7alpha
17alpha
ethynyl
prophylaxis
atherosclerosis
Prior art date
Application number
IL12342298A
Other languages
English (en)
Other versions
IL123422A0 (en
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL123422A0 publication Critical patent/IL123422A0/xx
Publication of IL123422A publication Critical patent/IL123422A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12342298A 1997-03-05 1998-02-24 USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS IL123422A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97200646 1997-03-05

Publications (2)

Publication Number Publication Date
IL123422A0 IL123422A0 (en) 1998-09-24
IL123422A true IL123422A (en) 2003-05-29

Family

ID=8228079

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12342298A IL123422A (en) 1997-03-05 1998-02-24 USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS

Country Status (21)

Country Link
EP (1) EP0994713B1 (de)
JP (1) JP2001515478A (de)
KR (1) KR100556558B1 (de)
CN (1) CN1159014C (de)
AR (1) AR015371A1 (de)
AT (1) ATE253366T1 (de)
AU (1) AU733758B2 (de)
BR (1) BR9808194A (de)
CA (1) CA2283418A1 (de)
DE (1) DE69819503T2 (de)
DK (1) DK0994713T3 (de)
ES (1) ES2210731T3 (de)
HK (1) HK1025510A1 (de)
HU (1) HUP0001499A3 (de)
IL (1) IL123422A (de)
NO (1) NO994305L (de)
PL (1) PL335904A1 (de)
TR (1) TR199902510T2 (de)
TW (1) TW448049B (de)
WO (1) WO1998039012A1 (de)
ZA (1) ZA981731B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
IL141850A (en) * 1998-10-16 2005-11-20 Akzo Nobel Nv High purity composition comprising (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-3n-20-yn-3-one

Also Published As

Publication number Publication date
AU733758B2 (en) 2001-05-24
CN1252723A (zh) 2000-05-10
JP2001515478A (ja) 2001-09-18
KR20000075966A (ko) 2000-12-26
ZA981731B (en) 1998-09-07
EP0994713B1 (de) 2003-11-05
DE69819503D1 (de) 2003-12-11
EP0994713A1 (de) 2000-04-26
NO994305L (no) 1999-11-01
NO994305D0 (no) 1999-09-03
HUP0001499A2 (hu) 2000-11-28
CA2283418A1 (en) 1998-09-11
ATE253366T1 (de) 2003-11-15
DE69819503T2 (de) 2004-09-23
AR015371A1 (es) 2001-05-02
AU6728498A (en) 1998-09-22
ES2210731T3 (es) 2004-07-01
DK0994713T3 (da) 2004-03-08
PL335904A1 (en) 2000-05-22
IL123422A0 (en) 1998-09-24
TW448049B (en) 2001-08-01
BR9808194A (pt) 2000-05-16
HK1025510A1 (en) 2000-11-17
KR100556558B1 (ko) 2006-03-06
HUP0001499A3 (en) 2001-03-28
TR199902510T2 (xx) 2000-02-21
CN1159014C (zh) 2004-07-28
WO1998039012A1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
HUP0104709A3 (en) Use of erythropoietin or erythropoietin derivatives for the manufacture of a medicament for treatment of cerebral ischaemia
ZA959100B (en) Azetidinone derivatives for the treatment of atherosclerosis
EP0711559A3 (de) Verwendung von Phosphatidylserinen zur Herstellung eines Arzneimittels zur Verbesserungen der Gehirntätigkeit
EP1191941A4 (de) Methode der prophylaxe und/oder behandlung von erkrankungen
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
HUP9702042A3 (en) Use of 1,1,2-triphenil but-1-ene derivatives for the production of medicaments against atherosclerosis
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
IL127496A0 (en) The use of MMP inhibitors for the treatment of ocular angiogenesis
HK1034465A1 (en) Egr-1 for the manufacturing of a medicament for treating wounds
AU3728095A (en) Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis
AU3187595A (en) Compounds for the treatment of restenosis
HUP0103826A3 (en) A process for the preparation of zofenopril calcium salt and medicament containing it and its use
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
IL123422A0 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
IL133739A0 (en) Shaped products or structures for medical or related purposes
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU1176295A (en) Orthopedic casts
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
AU1991199A (en) A preparation for the treatment of aphtae

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
MM9K Patent not in force due to non-payment of renewal fees